Introduction
Glomangiopericytoma belongs to a spectrum of lesions which include myofibromatosis, myofibroma, and subset of sinonasal hemangiopericytomas. [1, 2] Stout and Murray in 1942 initially reported GPC as hemangiopericytoma, the tumors displaying a characteristic well developed 'staghorn' branching vascular pattern [2] Over the years this definition has been questioned and hemangiopericytoma was better considered as a diagnosis of exclusion, as it appeared that this growth pattern was non-specific, shared by numerous, unrelated benign and malignant lesions and that GPC and SFT belongs to category of lesions which are individualised within the heterogeneous group of hemangiopericytoma -like neoplasms. [2] GPC characteristically has a component of cells with glomus type features including cuboidal cells, distinct cell borders, clear to eosinophilic cytoplasm and central round nuclei. Glomus tumors involving, internal organs are very rare and most often situated in GIT. In GIT, tumors usually involve the stomach but tumor developing in the omentum have not been reported. [3] We report a case of GPC of omentum and challenges we faced in immunohistochemistry interpretation based on literature review.
Case Report
A 46 year's old women presented with diffuse abdominal pain and abdominal lump of 4 months duration. Abdominal ultrasonography revealed a large soft tissue density mass below the anterior abdominal wall, possibly Omental/mesenteric origin/ ovarian in origin. CT abdomen pelvis showed large heterogeneously enhancing soft tissue density lesion seen along the parietal peritoneum, favoring peritoneal lesion, likely benign lesion with differential diagnosis of desmoid or peritoneal lymphangioma. (Fig. 1a) Intraoperatively cystic mass was located on the lesser curvature of the stomach. This mass was resected and sent for histopathological examination. Grossly, single brown cystic mass measuring 18 × 16 × 3 cm was received with cut surface showing solid and cystic areas. (Fig. 2a) Microscopy revealed unencapsulated lesion composed of numerous dilated vascular spaces filled with pale eosinophilic material. Amidst vascular spaces are seen oval to spindle cells, which occasionally show concentric growth pattern around blood vessels. These cells have amphophilic cytoplasm and at places clear with oval to spindle nuclei. (Fig. 2b, c and d ) Areas show lymphocytic infiltrate. Based on histology diagnosis of Glomangiopericytoma was given. The tumor was diffusely positive for CD34, focally positive for smooth muscle actin and Ki-67 proliferation rate of 1-2 %. (Fig. 3a , b and c) Tumor was negative for pancytokeratin and CD 117 (Fig. 3d, e ).
Discussion
Hemangiopericytoma originally described by Stout and Murray in 1942, as distinctive soft tissue neoplasm, presumably of pericytic origin, displaying characteristic well developed 'staghorn' branching vascular pattern. Over the years, three categories of lesion are individualised within heterogeneous group of HPC -like neoplasms. The first category corresponds to non-HPC neoplasms that occasionally display HPC-like features. Lesions belonging to second category show clear evidence of myoid/pericytic differentiation and correspond to true HPC's. The third category is SFT and related lesions. (Table 1 ) [2] . In 1998, Granter and colleagues conventionally used the term myopericytoma and comprehensively described three morphological appearances that formed a spectrum of tumors seen in the putative myopericytoma category. These tumor types were that of myofibromatosis, archetypal myopericytoma, and glomangiopericytoma. In the recent WHO classification of soft tissue tumors myopericytoma and myofibroma are listed as separate entities and glomangiopericytoma appears as a subtype of myopericytoma. [4] . The term glomangiopericytoma has been used recently for glomus tumors with prominent thin and thick walled vessels and slight spindling of the glomus cells. [5] . Extra thoracic soft tissue SFT's represent less than 2 % of all soft tissue tumors. [6] Clnically, usually presents as slowgrowing mass in middle aged adults. The most common extraserosal locations are retroperitoneum, deep soft tissues of proximal extremities, abdominal cavity, trunk, and head and neck. [2] .
The pathogenesis of glomangiopericytoma is still ambiguous and previous trauma, hypertension and prolonged steroid use have been speculated to be possible causes [7] Our patient, in this case does not have the past histories of trauma, hypertension and steroid use. Many cases mainly arising in the nasal cavity, [7] [8] [9] [10] [11] [12] paranasal sinuses, skull base [1] , extremities and stomach [3, 13] have been reported, but to our knowledge there has been no previous report of glomangiopericytoma in the omentum. It is worthy to note because it is rare to find such tumors in that region.
Gross examination of glomangiopericytoma usually reveals beefy red to grayish pink mass, soft, odematous or hemorrhagic in appearance. Rarely there may be regional lymphnode involvement. [7] Histological examination is important for diagnosis. Hematoxylin-eosin staining shows well demarcated but unencapsulated cellular tumor, characterized by diffuse growth of closely packed cells, forming short fascicles and sometimes display storiform, whorled or palisaded, frequently there is a combination of different patterns, interspersed with numerous thin walled and branching staghorn vessels. The neoplastic cells are uniform and elongated to oval, with round to spindle-shaped nuclei and lightly eosinophilic cytoplasm with indistinct cell membranes imparting a syncytial appearance. [7, 9, 14] In addition to spindle cells, occasional tumors have foci with a more round-cell appearance, resembling glomus tumor, as observed in our case. [8] Generally there is low mitotic activity and nuclear pleomorphism is absent or minimal. [7, 9] A small percentage of tumors may demonstrate tumor giant cells, clear cells, or myxoid degeneration. Most tumors have areas with inflammatory cells and extravasated blood vessels, as observed in our case. [8] .
Grossly, SFT are usually well-demarcated and partially encapsulated neoplasms. Microscopically, they show wide range of morphological features, from predominantly fibrous lesions containing large collagenized areas and thick/hyalinized walled vessels to more cellular and less fibrous neoplasms. [2] . Differentiating hemangiopericytomas and solitary fibrous tumors based on immunohistochemistry is a challenge. Glomangiopericytomas are true pericytic tumors exhibiting a myoid phenotype. On immunohistochemistry, they express vimentin, smooth muscle actin, muscle specific actin with staining typically diffuse and strong but sometimes focal. They are also positive for factor XIIIa. In 2010, Dandekar reported that staining for desmin, S100 protein, and CD34 is typically negative, although staining for CD 34 and S100 protein can be focally and weakly positive in small percentage of glomangiopericytomas. [8] Characteristically, CD34 is reported negative in many case studies. [1, [7] [8] [9] Additional negative stains include Bcl-2, CD99, CD117, and cytokeratins. [7, 8] We observed diffuse positivity for CD 34 and focal positivity for smooth muscle actin. Immonohistochemically neoplastic cells of solitary fibrous tumor, especially fibrous forms stain positive for CD 34 with less consistent actin staining, [2, 8] but histologically lack myoid differentiation and perivascular hyalinization. (Table 2) .
Glomangiopericytoma is indolent tumor associated with 5-year survival greater than 90 % after complete surgical resection. [12] Local recurrence has been reported in 7 % to 40 % of cases, in part because of incomplete surgical resection; however, aggressive behavior is rare. [1, 7] Metastatic disease and disease related mortality is extremely rare (3 %). Thus regular follow-up postoperatively is essential. [7] Our patient is followed for two years without any evidence of recurrence or metastases. As with regard to SFT, enbloc resection remains the cornerstone of therapy for curative intent. [6] .
In conclusion, glomangiopericytoma and SFT are rare benign mesenchymal neoplasms. Since patients have no specific clinical and imaging findings, it is difficult to diagnose preoperatively. Histopathological features and multiple immunohistochemistry markers are essential to make its diagnosis. To our knowledge, this is the first reported case affecting lesser omentum. 
